TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head November 24, 1989